Topical Collection on New Therapies for Cardiovascular Disease

ISSN: 1523-3782 (Print) 1534-3170 (Online)

In this topical collection (27 articles)

previous disabled Page of 2
  1. No Access

    New Therapies for Cardiovascular Disease (KW Mahaffey, Section Editor)

    Heart Failure with Preserved Ejection Fraction: Current Understandings and Challenges

    Mads J. Andersen, Barry A. Borlaug Article:501
  2. No Access

    New Therapies for Cardiovascular Disease (KW Mahaffey, Section Editor)

    Overview of the US FDA Medical Device Approval Process

    Ashwani Sastry Article:494
  3. No Access

    New Therapies for Cardiovascular Disease (KW Mahaffey, Section Editor)

    Cangrelor: Review of the Drug and the CHAMPION Programme (Including PHOENIX)

    Marcello Marino, Diego Rizzotti, Sergio Leonardi Article:493
  4. No Access

    New Therapies for Cardiovascular Disease (KW Mahaffey, Section Editor)

    Universal MI Definition Update for Cardiovascular Disease

    Harvey White, Kristian Thygesen, Joseph S. Alpert Article:492
  5. No Access

    New Therapies for Cardiovascular Disease (KW Mahaffey, Section Editor)

    Intracranial Hemorrhage and Novel Anticoagulants for Atrial Fibrillation: What Have We Learned?

    Graeme J. Hankey Article:480
  6. No Access

    New Therapies for Cardiovascular Disease (K Mahaffey, Section Editor)

    PCSK9 Inhibitors: Potential in Cardiovascular Therapeutics

    Rose Q. Do, Robert A. Vogel, Gregory G. Schwartz Article:345
  7. No Access

    New Therapies for Cardiovascular Disease (K Mahaffey, Section Editor)

    Approaches to Decongestion in Patients with Acute Decompensated Heart Failure

    Daniel Muñoz, G. Michael Felker Article:335
  8. No Access

    New Therapies for Cardiovascular Disease (K Mahaffey, Section Editor)

    Novel Pharmacologic Therapies in Development for Acute Decompensated Heart Failure

    Justin A. Ezekowitz Article:329
  9. No Access

    New Therapies for Cardiovascular Disease (K Mahaffey, Section Editor)

    Impediments to Adherence to Post Myocardial Infarction Medications

    Nihar R. Desai, Niteesh K. Choudhry Article:322
  10. No Access

    New Therapies for Cardiovascular Disease (K Mahaffey, Section Editor)

    Platelet Function Monitoring and Clopidogrel

    Andrew R. Harper, Matthew J. Price Article:321
  11. No Access

    New Therapies for Cardiovascular Disease (AA Bavry, Section Editor)

    Chronic Total Occlusion Interventions: Update on Current Tips and Tricks

    Peter Tajti, Iosif Xenogiannis, Dimitris Karmpaliotis Article:141
  12. No Access

    New Therapies for Cardiovascular Disease (AA Bavry, Section Editor)

    Is There a Safety Concern for Drug-Coated Balloons in Peripheral Arterial Disease?

    Mohamed M. Gad, Antonette K. Karrthik, Ahmad A. Mahmoud Article:126
  13. No Access

    New Therapies for Cardiovascular Disease (AA Bavry, Section Editor)

    Cath Lab Robotics: Paradigm Change in Interventional Cardiology?

    Zachary K. Wegermann, Rajesh V. Swaminathan, Sunil V. Rao Article:119
  14. No Access

    New Therapies for Cardiovascular Disease (KW Mahaffey, Section Editor)

    Renal Denervation: Where to Now?

    Neil J. Wimmer, Laura Mauri Article:116
  15. No Access

    New Therapies for Cardiovascular Disease (AA Bavry, Section Editor)

    Current Role of the CardioMEMS Device for Management of Patients with Heart Failure

    Calvin C. Leung Article:98
  16. No Access

    New Therapies for Cardiovascular Disease (AA Bavry, Section Editor)

    Ulnar Artery Catheterization: Is This Our Second Access Site or Is It Still Femoral?

    Mladen I. Vidovich Article:91
previous disabled Page of 2